Wellington Management Group LLP Neurocrine Biosciences Inc Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 2,097,981 shares of NBIX stock, worth $252 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,097,981

Holding current value

$252 Million

% of portfolio

0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$107.22 - $153.29 $225 Million - $322 Million	2,097,981 New	2,097,981 $232 Million
Q4 2024 Feb 12, 2025	BUY	$111.62 - $139.44 $82.5 Million - $103 Million	739,199 Added 102.92%	1,457,425 $199 Million
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $20.8 Million - $27.8 Million	-181,267 Reduced 20.15%	718,226 $82.7 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $13.6 Million - $14.9 Million	-104,257 Reduced 10.39%	899,493 $124 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $131 Million - $144 Million	1,003,750 New	1,003,750 $138 Million
Q4 2023 Feb 12, 2024	BUY	$106.07 - $132.76 $127 Million - $159 Million	1,199,542 New	1,199,542 $158 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $6.72 Million - $8.37 Million	-71,500 Reduced 5.11%	1,327,939 $149 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $20.4 Million - $24 Million	228,393 Added 19.5%	1,399,439 $132 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $3.29 Million - $4.31 Million	-35,007 Reduced 2.9%	1,171,046 $119 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $46.6 Million - $55.5 Million	436,603 Added 56.74%	1,206,053 $144 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $29.9 Million - $35.1 Million	325,301 Added 73.24%	769,450 $81.7 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $4.15 Million - $5.48 Million	54,741 Added 14.06%	444,149 $43.3 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $28.2 Million - $36.9 Million	389,408 New	389,408 $36.5 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $2.07 Million - $2.76 Million	-26,029 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $1.02 Million - $1.17 Million	-11,799 Reduced 31.19%	26,029 $2.5 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $25,129 - $28,737	-281 Reduced 0.74%	37,828 $3.68 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $156,925 - $213,964	-1,792 Reduced 4.49%	38,109 $3.71 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $1.36 Million - $1.7 Million	15,683 Added 64.76%	39,901 $3.82 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $537,053 - $754,812	-5,585 Reduced 18.74%	24,218 $2.33 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $1.07 Million - $1.64 Million	-12,549 Reduced 29.63%	29,803 $3.64 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $1.25 Million - $1.9 Million	-16,679 Reduced 28.25%	42,352 $3.67 Million
Q4 2019 Feb 11, 2020	BUY	$86.8 - $118.57 $5.12 Million - $7 Million	59,031 New	59,031 $6.35 Million

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

97.2M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Neurocrine Biosciences Inc Transaction History